The research group in hematology is devoted to clinical and translational trials in hematology, focused on diagnosis, prognosis and the development of new therapies to treat hematological malignancies such as leukemias and myelomas.
The group uses a variety of approaches such as genetic studies of the immune response, pharmacogenomics in response to treatment, analysis of polymorphisms as disease predictors and the study of cell populations using flow cytometry for the characterization of residual disease.
Through our research, we aim to:
- Investigate biological, clinical, and epidemiological aspects of hematological diseases.
- Carry out translational research projects focused on finding prognostic factors or treatment response predictors.
- Carry out clinical research, promoting participation in clinical trials for hematological diseases and participating in national and international cooperative groups.
|David Gallardo||Group Leaderemail@example.com|
|Anna Angona Figueras||Attending Physician|
|Gemma Osca Gelis||Postdoctoral Researcher|
|Yolanda González Montes||PhD Student|
|Johana Alejandra Diaz Santa||PhD Student|
|Nazly Santos Carvajal||PhD Student|
|David Cruz García||PhD Student|
|Josep Maria Ronccero Vidal||Associate Investigator|
|Esperanza Tuset Andújar||Associate Investigator|
|Rosa Coll Jordà||Associate Investigator|
|Natalia Lloveras Guelque||Associate Investigator|
|Nichollas John Kelleher||Associate Investigator|
|Antonio Blanco Blanco||Associate Investigator|
|Anna Bustins Tarrats||Associate Investigator|
|Silvia Zdenka Mostacedo Marasovic||Associate Investigator|
|Marta Sitges Arriaga||Associate Investigator|
|Jordi Vila Bou||Associate Investigator|
|Rocío Rodríguez Romanos||Technician|
|Marta González Bártulos||Technician|